Attention.
Just one of the benefits of Adderall XR in ADHD

-Demonstrated significant improvement in attention
-Demonstrated significant improvement in performance

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Search

Did you know you could search pharmaceutical ads by color on AdPharm?

Most of the ads in the gallery now have color tags. This can be useful when it’s time to decide on the colors for a new brand or when the time comes to create a new ad. To do this, you just type in the color name in the search box on any of the pages on AdPharm. Read the rest of this entry »

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on the image to see the full-sized ad and get all the info on AdPharm.

Many more NSAID treatment ads on AdPharm, click here

Now approved for acquired hemophilia
With a life-threatening acquired hemophilia bleed, every minute counts.
Stop it with NovoSeven

For options on how to access NovoSeven, go to accessnovoseven.com or call 1-877-NOVO-777

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage. The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999. The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O'Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: USA, North America
Indication(s)/use: uncontrollable hemorrhage, acquired haemophilia
Target: Healthcare Professionals (HCP)
Tagline: Let nothing inhibit their passion
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009

Visit AdPharm.net for more pharmaceutical ads

Campaign for Aptamil follow-on milk that was banned by the ASA for making misleading claims.

[Voice-over]
Breast milk is perfect for your baby. Nothing compares to it.
It strengthens your baby’s natural defenses and reduces the risk of infection. How time flies by.
If you decide to move on from breasting, Aptamil follow on contains Immunofortis to help support some of your baby’s natural defenses.

Aptamil follow on. Helping support your baby.

Agency: Leo Burnett

Brand name: Aptamil
Generic name/category: infant milk
Company: Nutricia
Country/Market: UK, Europe
Indication(s)/use: Food supplement
Target: Consumers (DTC)
Tagline: To help support some of your baby’s natural defences
Medium: TV commercial
Size/duration: 30 seconds
Publication/Aired: 2009
Source: Guardian UK

Now approved for acquired hemophilia
With a life-threatening acquired hemophilia bleed, every minute counts.
Stop it with NovoSeven

For options on how to access NovoSeven, go to accessnovoseven.com or call 1-877-NOVO-777

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage. The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999. The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O'Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: USA, North America
Indication(s)/use: uncontrollable hemorrhage, acquired haemophilia
Target: Healthcare Professionals (HCP)
Tagline: Let nothing inhibit their passion
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009